BioSpace News Archive

Commissioned by Tianqiao and Chrissy Chen Institute, the film shows that increased support for fundamental brain research is crucial to achieve major breakthroughs. [05-September-2018] MENLO PARK, Calif., Sept. 5, 2018 /PRNewswire/ -- The Tianqiao and Chrissy

Bio-Techne Corporation today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Morgan Stanley 16th Annual Global Healthcare Conference on Thursday, September 13, 2018, at 8:00 a.m. EDT.

Through the support of Jigsaw Health, Shape Up Us has introduced a new MINERAL POWER curriculum with an emphasis on Magnesium as part of the Hip Hop Healthy Program for Children™.

Feasibility studies show excellent data with SB010 across a selection of high efficiency hand-held nebulizers.

Please be advised that the Honourable Jane Philpott, Minister of Indigenous Services will be in Winnipeg on Thursday, September 6, 2018, and will participate in two announcements.

BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife”), the leading supplier of proprietary biopreservation media products for cell and gene therapies, today announced that it has increased its ownership of SAVSU Technologies from approximately 31% to 44% with a $5 million investment

Cantel Medical Corp. (NYSE: CMD), a leading global company dedicated to delivering innovative infection prevention products, services and solutions, announced today that it has recently purchased a new office building at 9800 59th Ave. N. in Plymouth, Minnesota that has capacity for approximately 600 employees.

AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life, and Metrion Biosciences Limited (“Metrion”), the specialist ion channel CRO and drug discovery company, today announced they have signed a new collaboration agreement.

Moderna Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Dr. Wellington Sun will join the company as its Head, Vaccine Strategy and Regulatory Affairs, starting later this month.

This year marks ENT and Allergy Associates LLP’s (ENTA) 20-year milestone since its inception.